Forest Laboratories has provided Nabriva Therapeutics with $25m to fund and collaborate on the company’s new antibiotic drug during the next 12 months.
During the 12-month period, Forest has the exclusive right to acquire Nabriva.
Forest Laboratories has provided Nabriva Therapeutics with $25m to fund and collaborate on the company’s new antibiotic drug during the next 12 months.
During the 12-month period, Forest has the exclusive right to acquire Nabriva.